CLINICAL_FABRIC_SOLUTIONS - Accounts


CLINICAL FABRIC SOLUTIONS LTD
Company Registration No. 09978091 (England and Wales)
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2017
PAGES FOR FILING WITH REGISTRAR
CLINICAL FABRIC SOLUTIONS LTD
COMPANY INFORMATION
Directors
Mr J  Themans
(Appointed 29 January 2016)
Prof M G Mythen
(Appointed 31 October 2016)
Company number
09978091
Registered office
First Floor
15-17 Whitburn Street
Bridgnorth
Shropshire
WV16 4QN
Accountants
Dyke Yaxley Limited
1 Brassey Road
Old Potts Way
Shrewsbury
Shropshire
SY3 7FA
CLINICAL FABRIC SOLUTIONS LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CLINICAL FABRIC SOLUTIONS LTD
BALANCE SHEET
AS AT
31 JANUARY 2017
31 January 2017
- 1 -
2017
Notes
£
£
Fixed assets
Intangible assets
2
50,000
Current assets
Debtors
3
21,243
Cash at bank and in hand
81,282
102,525
Creditors: amounts falling due within one year
4
(3,108)
Net current assets
99,417
Total assets less current liabilities
149,417
Capital and reserves
Called up share capital
5
1,120
Share premium account
199,920
Profit and loss reserves
(51,623)
Total equity
149,417

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 31 January 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

T he directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.he directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 .he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 25 July 2017 and are signed on its behalf by:
Mr J  Themans
Director
Company Registration No. 09978091
CLINICAL FABRIC SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2017
- 2 -
1
Accounting policies
Company information

Clinical Fabric Solutions Ltd is a private company limited by shares incorporated in England and Wales. The registered office is First Floor, 15-17 Whitburn Street, Bridgnorth, Shropshire, WV16 4QN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Reporting period

These financial statements for the company relate to a longer period ended 31 January 2017 as this was the first reporting period.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date if the fair value can be measured reliably.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
10% Straight line from trade commencement date
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

CLINICAL FABRIC SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JANUARY 2017
1
Accounting policies
(Continued)
- 3 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

CLINICAL FABRIC SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JANUARY 2017
1
Accounting policies
(Continued)
- 4 -
1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Intangible fixed assets
Other
£
Cost
At 29 January 2016
-
Additions
50,000
At 31 January 2017
50,000
Amortisation and impairment
At 29 January 2016 and 31 January 2017
-
Carrying amount
At 31 January 2017
50,000
3
Debtors
2017
Amounts falling due within one year:
£
Other debtors
21,243
4
Creditors: amounts falling due within one year
2017
£
Trade creditors
1,608
Other creditors
1,500
3,108
5
Called up share capital
2017
£
Ordinary share capital
Issued and fully paid
1,120 Ordinary 'A' shares of £1 each
1,120
2017-01-31falseCCH SoftwareCCH Accounts Production 2017.1102016-01-29No description of principal activity2017-07-25099780912016-01-292017-01-3109978091bus:Director12016-01-292017-01-3109978091bus:Director22016-01-292017-01-3109978091bus:RegisteredOffice2016-01-292017-01-31099780912017-01-3109978091core:OtherResidualIntangibleAssets2017-01-3109978091core:IntangibleAssetsOtherThanGoodwill2017-01-3109978091core:CurrentFinancialInstruments2017-01-3109978091core:ShareCapital2017-01-3109978091core:SharePremium2017-01-3109978091core:RetainedEarningsAccumulatedLosses2017-01-3109978091core:Non-currentFinancialInstruments2017-01-3109978091bus:OrdinaryShareClass12016-01-292017-01-3109978091bus:OrdinaryShareClass12017-01-3109978091bus:PrivateLimitedCompanyLtd2016-01-292017-01-3109978091bus:FRS1022016-01-292017-01-3109978091bus:AuditExemptWithAccountantsReport2016-01-292017-01-3109978091bus:FullAccounts2016-01-292017-01-31xbrli:purexbrli:sharesiso4217:GBP